The Boston-based company plans to use the funds to accelerate the commercialization of its Neurable AI brain-signal processing technology. Its patented compact brain-signal processing technology integrates BCI capabilities into devices that people use every day.
With the latest funding, led by Spectrum Moonshot Fund, the company reports $65 million in total funds raised.
Neurable said the funds spur its next stage of growth as it looks to bring advanced neurotechnology into daily routines. The company hopes to make brain insights as accessible as heart rate or sleep tracking. Last year, it introduced the MW75 Neuro LT BCI-enabled headphones, along with the newly updated app that provides real-time cognitive insights on mental fatigue, cognitive recovery and focus state detection.
The company says its AI capabilities power the technology. It expects the funding to expand its neurotechnology platform across the broader cognitive health and human performance ecosystem.
“Our mission is to make understanding your brain as natural and intuitive as checking your steps,” said Dr. Ramses Alcaide, CEO and co-founder of Neurable. “With the MW75 Neuro LT and the redesigned Neurable app, people can finally see how their mind performs throughout the day. This funding allows us to scale Neurable AI into new devices and new industries, making cognitive health an accessible, daily utility for everyone.”
